Similar companies
| Company | Stocktwits Subscribers | |
|---|---|---|
![]() |
AmgenAMGN |
14,775 0% |
![]() |
Gilead SciencesGILD |
77,729 0% |
![]() |
Catalyst PharmaceuticalsCPRX |
15,776 0% |
![]() |
Inovio PharmaceuticalsINO |
92,264 0% |
![]() |
BridgeBio PharmaBBIO |
5,389 0% |
Month over Month
Subscribing Stocktwits Users
| Feb 2026 | 24,363 | |
| Jan 2026 | 24,442 | |
| Dec 2025 | 24,499 | |
| Nov 2025 | 24,173 | |
| Oct 2025 | 23,646 |
How many users are following Anavex Life Sciences on StockTwits?
The interest in Anavex Life Sciences on StockTwits is decent, with a following of 19,442 investors.
Analyzing Stocktwits Subscribers, how is Anavex Life Sciences performing compared to its industry peers?
Anavex Life Sciences underperforms its industry peers when it comes to Stocktwits Subscribers, ranking in the 16th percentile.
What has been the change in Anavex Life Sciences' StockTwits followers over the past month?
There has been no meaningful change in the number of followers in the last month.
What is StockTwits?
StockTwits is a social media platform designed specifically for the investing community. It enables investors and traders to share market insights, strategies, and real-time news updates. Essentially, it's a specialized network for financial market discussions, often characterized by brief, tweet-like posts.
Why is it important for Anavex Life Sciences investors to monitor its StockTwits followers?
For investors in Anavex Life Sciences, tracking the number of followers on StockTwits can be highly beneficial. The platform's follower count offers a direct gauge of investor interest and sentiment surrounding Ford. An increasing follower count typically suggests growing investor attention and can be an indicator of rising market enthusiasm or concern about the company's prospects. This data can provide investors with valuable insights into market trends, potential shifts in investor behavior, and broader perceptions of Ford in the investment community.
Sign up and get more insights on Anavex Life Sciences.




